Abbratech
abbratech.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$8.5M
10 rounds on record
Latest round
$8.5M
Venture round · Nov 2023 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$7.3M
9 grants · CORDIS
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1, 2025
Won a grant $551k · CORDIS
Sep 20, 2024
Won a grant $206k · CORDIS
Jun 24, 2024
Won a grant $996k · CORDIS
Sep 19, 2023
Won a grant $2.2M · CORDIS
Jul 1, 2023
Won a grant $295k · CORDIS
May 5, 2023
Won a grant $296k · CORDIS
Feb 1, 2023
Won a grant $2.2M · CORDIS
2023
Founded
Jun 1, 2022
Won a grant $253k · CORDIS
Apr 1, 2022
Won a grant $339k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Aug 2025 | $551k | — | CORDIS |
| Grant | Sep 2024 | $206k | — | CORDIS |
| Grant | Jun 2024 | $996k | — | CORDIS |
| Venture round | Nov 2023 | $8.5M | — | SEC Form D |
| Grant | Sep 2023 | $2.2M | — | CORDIS |
| Grant | Jul 2023 | $295k | — | CORDIS |
| Grant | May 2023 | $296k | — | CORDIS |
| Grant | Feb 2023 | $2.2M | — | CORDIS |
| Grant | Jun 2022 | $253k | — | CORDIS |
| Grant | Apr 2022 | $339k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | AbbraTech Holdings LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Michael WeinerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
KisoJi Biotechnology. Breakthrough antibody discovery forbreakthrough therapeutics.
immunitoAI is an AI-driven biotechnology company accelerating antibody discovery and the development of antibody-based therapies through…
Advanced Antibody Design Services. Macromoltek harnesses the power of computational modeling and artificial intelligence to accelerate and…
Technology. Dreamfold develops generative AI models to unlock more effective therapies for cancer, immune diseases, and other serious…
HERlab. Novel low COGS antibody expression systems.
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…
Overview
A Novel Platform for Antibody Discovery, Engineering and Validation. Antibody therapies are an increasingly important tool for treating diseases like cancer, immune disorders, and viral infections.
People
Michael Weiner
Executive Officer, Director
Sean Cassidy
Director
Michael Egholm
Director
Kenan Turnacioglu
Director
Sean Mackay
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Guilford
United States
HQ
Branford
United States
Regional office
25 Business Park Drive, Suite C,
25 Business Park Drive, Suite C,, Branford CT 06405
Financials
Total raised
$15.8M
Latest round
Grant
Funding rounds
10
Funding rounds